{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:20Z","timestamp":1747207280889,"version":"3.40.5"},"reference-count":55,"publisher":"Bentham Science Publishers Ltd.","issue":"20","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Heart failure is a major problem in developed countries, leading to a high number of hospitalizations\nand healthcare costs. The most common symptom of heart failure is congestion, which is also the primary reason\nfor hospitalization. Diuretics, particularly loop diuretics, are the cornerstone of the treatment of congestion.\nLikewise, there are other types of diuretics with different pathways of action, bioavailability profiles, adverse reactions,\nand effects on the cardiovascular and renal systems. Moreover, in recent years, new therapeutic alternatives\nhave been proposed for challenging cases of diuretic resistance, such as ultrafiltration through peripheral\naccess or peritoneal dialysis. The main objective of this article is to provide a step-guided approach to the management\nof congestion in patients with heart failure in order to guide the medical practice. Despite the significant\namount of research published in recent years, there are no clear algorithms for managing acute heart failure.\nDiuretics remain the primary treatment of acute heart failure, and nephron blockade is key, but new therapies\nare emerging, and ongoing research is needed to develop better strategies for managing this condition.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666230714153404","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T05:46:33Z","timestamp":1689572793000},"page":"1592-1601","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of the Treatment of Congestion in Heart Failure"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-3531","authenticated-orcid":true,"given":"Julia","family":"Martinez-Sole","sequence":"first","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Carlos","family":"Sanchez-Martinez","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Lopez-Vilella","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Donoso-Trenado","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Sanchez-Lazaro","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biomedica en Red (CIBERCV)-Madrid,\nSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Almenar-Bonet","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biomedica en Red (CIBERCV)-Madrid,\nSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Sanz-Sanchez","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biomedica en Red (CIBERCV)-Madrid,\nSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Martinez-Dolz","sequence":"additional","affiliation":[{"name":"Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain"},{"name":"Centro de Investigaci\u00f3n Biomedica en Red (CIBERCV)-Madrid,\nSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Libby P.","year":"2021","unstructured":"Libby P.; Bonow R.O.; Mann D.L.; Tomaselli G.F.; Bhatt D.; Solomon S.D.; Braunwald E.;  Braunwald\u2019s Heart Disease-E-Book: A Textbook of Cardiovascular Medicine 2021","journal-title":"Braunwald\u2019s Heart Disease-E-Book: A Textbook of Cardiovascular Medicine"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11897-015-0273-5","volume":"12","author":"Martens P.","year":"2015","unstructured":"Martens P.; Nijst P.; Mullens W.; Current approach to decongestive therapy in acute heart failure. Curr Heart Fail Rep 2015,12(6),367-378","journal-title":"Curr Heart Fail Rep"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","volume":"17","author":"Boorsma E.M.","year":"2020","unstructured":"Boorsma E.M.; ter Maaten J.M.; Damman K.; Dinh W.; Gustafsson F.; Goldsmith S.; Burkhoff D.; Zannad F.; Udelson J.E.; Voors A.A.; Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol 2020,17(10),641-655","journal-title":"Nat Rev Cardiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","volume":"258","author":"Rubio-Gracia J.","year":"2018","unstructured":"Rubio-Gracia J.; Demissei B.G.; ter Maaten J.M.; Cleland J.G.; O\u2019Connor C.M.; Metra M.; Ponikowski P.; Teerlink J.R.; Cotter G.; Davison B.A.; Givertz M.M.; Bloomfield D.M.; Dittrich H.; Damman K.; P\u00e9rez-Calvo J.I.; Voors A.A.; Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol 2018,258,185-191","journal-title":"Int J Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"Heidenreich P.A.","year":"2022","unstructured":"Heidenreich P.A.; Bozkurt B.; Aguilar D.; Allen L.A.; Byun J.J.; Colvin M.M.; Deswal A.; Drazner M.H.; Dunlay S.M.; Evers L.R.; Fang J.C.; Fedson S.E.; Fonarow G.C.; Hayek S.S.; Hernandez A.F.; Khazanie P.; Kittleson M.M.; Lee C.S.; Link M.S.; Milano C.A.; Nnacheta L.C.; Sandhu A.T.; Stevenson L.W.; Vardeny O.; Vest A.R.; Yancy C.W.; 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure. J Am Coll Cardiol 2022,79(17),e263-e421","journal-title":"J Am Coll Cardiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh T.A.","year":"2021","unstructured":"McDonagh T.A.; Metra M.; Adamo M.; Gardner R.S.; Baumbach A.; B\u00f6hm M.; Burri H.; Butler J.; \u010celutkien\u0117 J.; Chioncel O.; Cleland J.G.F.; Coats A.J.S.; Crespo-Leiro M.G.; Farmakis D.; Gilard M.; Heymans S.; Hoes A.W.; Jaarsma T.; Jankowska E.A.; Lainscak M.; Lam C.S.P.; Lyon A.R.; McMurray J.J.V.; Mebazaa A.; Mindham R.; Muneretto C.; Francesco Piepoli M.; Price S.; Rosano G.M.C.; Ruschitzka F.; Kathrine Skibelund A.; de Boer R.A.; Christian Schulze P.; Abdelhamid M.; Aboyans V.; Adamopoulos S.; Anker S.D.; Arbelo E.; Asteggiano R.; Bauersachs J.; Bayes-Genis A.; Borger M.A.; Budts W.; Cikes M.; Damman K.; Delgado V.; Dendale P.; Dilaveris P.; Drexel H.; Ezekowitz J.; Falk V.; Fauchier L.; Filippatos G.; Fraser A.; Frey N.; Gale C.P.; Gustafsson F.; Harris J.; Iung B.; Janssens S.; Jessup M.; Konradi A.; Kotecha D.; Lambrinou E.; Lancellotti P.; Landmesser U.; Leclercq C.; Lewis B.S.; Leyva F.; Linhart A.; L\u00f8chen M-L.; Lund L.H.; Mancini D.; Masip J.; Milicic D.; Mueller C.; Nef H.; Nielsen J-C.; Neubeck L.; Noutsias M.; Petersen S.E.; Sonia Petronio A.; Ponikowski P.; Prescott E.; Rakisheva A.; Richter D.J.; Schlyakhto E.; Seferovic P.; Senni M.; Sitges M.; Sousa-Uva M.; Tocchetti C.G.; Touyz R.M.; Tschoepe C.; Waltenberger J.; Adamo M.; Baumbach A.; B\u00f6hm M.; Burri H.; \u010celutkien\u0117 J.; Chioncel O.; Cleland J.G.F.; Coats A.J.S.; Crespo-Leiro M.G.; Farmakis D.; Gardner R.S.; Gilard M.; Heymans S.; Hoes A.W.; Jaarsma T.; Jankowska E.A.; Lainscak M.; Lam C.S.P.; Lyon A.R.; McMurray J.J.V.; Mebazaa A.; Mindham R.; Muneretto C.; Piepoli M.F.; Price S.; Rosano G.M.C.; Ruschitzka F.; Skibelund A.K.; 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021,42(36),3599-3726","journal-title":"Eur Heart J"},{"key":"ref=7","author":"Koeppen B.M.","year":"2021","unstructured":"Koeppen B.M.; Stanton B.A.;  Renal Physiology: Mosby Physiology Monograph Series 2021","journal-title":"Renal Physiology: Mosby Physiology Monograph Series"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","volume":"114","author":"Ellison D.H.","year":"1991","unstructured":"Ellison D.H.; The physiologic basis of diuretic synergism: Its role in treating diuretic resistance. Ann Intern Med 1991,114(10),886-894","journal-title":"Ann Intern Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","volume":"56","author":"Jentzer J.C.","year":"2010","unstructured":"Jentzer J.C.; DeWald T.A.; Hernandez A.F.; Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol 2010,56(19),1527-1534","journal-title":"J Am Coll Cardiol"},{"key":"ref=10","first-page":"00056","volume":"S1109-9666","author":"L\u00f3pez-Vilella R","unstructured":"L\u00f3pez-Vilella R; Jover-Pastor P; Donoso-Trenado V; Clinical phenotypes according to diuretic combination in acute heart failure. Hellenic J Cardiol ,S1109-9666(23),00056-8","journal-title":"Hellenic J Cardiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","volume":"111","author":"Murray M.D.","year":"2001","unstructured":"Murray M.D.; Deer M.M.; Ferguson J.A.; Dexter P.R.; Bennett S.J.; Perkins S.M.; Smith F.E.; Lane K.A.; Adams L.D.; Tierney W.M.; Brater D.C.; Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 2001,111(7),513-520","journal-title":"Am J Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","volume":"57","author":"Vargo D.L.","year":"1995","unstructured":"Vargo D.L.; Kramer W.G.; Black P.K.; Smith W.B.; Serpas T.; Brater D.C.; Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther 1995,57(6),601-609","journal-title":"Clin Pharmacol Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","volume":"4","author":"Cos\u00edn J.","year":"2002","unstructured":"Cos\u00edn J.; D\u00edez J.; Torasemide in chronic heart failure: Results of the TORIC study. Eur J Heart Fail 2002,4(4),507-513","journal-title":"Eur J Heart Fail"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","volume":"82","author":"Faris R.","year":"2002","unstructured":"Faris R.; Flather M.; Purcell H.; Henein M.; Poole-Wilson P.; Coats A.; Current evidence supporting the role of diuretics in heart failure: A meta analysis of randomised controlled trials. Int J Cardiol 2002,82(2),149-158","journal-title":"Int J Cardiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jacc.2020.06.022","volume":"76","author":"Faselis C.","year":"2020","unstructured":"Faselis C.; Arundel C.; Patel S.; Lam P.H.; Gottlieb S.S.; Zile M.R.; Deedwania P.; Filippatos G.; Sheriff H.M.; Zeng Q.; Morgan C.J.; Wopperer S.; Nguyen T.; Allman R.M.; Fonarow G.C.; Ahmed A.; Loop diuretic prescription and 30- day outcomes in older patients with heart failure. J Am Coll Cardiol 2020,76(6),669-679","journal-title":"J Am Coll Cardiol"},{"key":"ref=16","author":"Hall J.E.","year":"2011","unstructured":"Hall J.E.;  Guyton and Hall textbook of medical physiology 2011","journal-title":"Guyton and Hall textbook of medical physiology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"Felker G.M.","year":"2011","unstructured":"Felker G.M.; Lee K.L.; Bull D.A.; Redfield M.M.; Stevenson L.W.; Goldsmith S.R.; LeWinter M.M.; Deswal A.; Rouleau J.L.; Ofili E.O.; Anstrom K.J.; Hernandez A.F.; McNulty S.E.; Velazquez E.J.; Kfoury A.G.; Chen H.H.; Givertz M.M.; Semigran M.J.; Bart B.A.; Mascette A.M.; Braunwald E.; O\u2019Connor C.M.; Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011,364(9),797-805","journal-title":"N Engl J Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40292-021-00476-4","volume":"28","author":"L\u00f3pez-Vilella R.","year":"2021","unstructured":"L\u00f3pez-Vilella R.; S\u00e1nchez-L\u00e1zaro I.; Husillos Tamarit I.; Monte Boquet E.; N\u00fa\u00f1ez Villota J.; Donoso Trenado V.; Mart\u00ednez Dolz L.; Almenar Bonet L.; Administration of subcutaneous furosemide in elastomeric pump vs. oral solution for the treatment of diuretic refractory congestion. High Blood Press Cardiovasc Prev 2021,28(6),589-596","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","volume":"44","author":"Trull\u00e0s J.C.","year":"2023","unstructured":"Trull\u00e0s J.C.; Morales-Rull J.L.; Casado J.; Carrera-Izquierdo M.; S\u00e1nchez-Marteles M.; Conde-Martel A.; D\u00e1vila-Ramos M.F.; Ll\u00e1cer P.; Salamanca-Bautista P.; P\u00e9rez-Silvestre J.; Plas\u00edn M.\u00c1.; Cerqueiro J.M.; Gil P.; Formiga F.; Manzano L.; Morales J.L.; Sol\u00e9 C.; Carrera M.; Le\u00f3n M.; S\u00e1nchez M.; Horna V.G.; Conde A.; Meneses M.H.; D\u00e1vila M.F.; Carballo C.H.; Casado J.; Zabaleta J.P.; Iborra P.L.; Garc\u00eda M.C.M.; Trull\u00e0s J.C.; Bisbe J.; del Prado Salamanca Bautista M.; Bodas \u00d3.A.; Manzano L.; Ruiz R.; Silvestre J.P.; Plas\u00edn M.\u00c1.; Gonz\u00e1lez J.M.C.; Chivite D.; Formiga F.; Gil P.; Jordana R.; Villalonga M.; Rubio M.I.P.; Rodrigo J.M.C.; P\u00e9rez-Barquero M.M.; Muela A.; Mateos L.; Grau J.; Armengou A.; Herrero A.; L\u00f3pez R.Q.; Combining loop with thiazide diuretics for decompensated heart failure: The CLOROTIC trial. Eur Heart J 2023,44(5),411-421","journal-title":"Eur Heart J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"Pitt B.","year":"1999","unstructured":"Pitt B.; Zannad F.; Remme W.J.; Cody R.; Castaigne A.; Perez A.; Palensky J.; Wittes J.; The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999,341(10),709-717","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"Zannad F.","year":"2011","unstructured":"Zannad F.; McMurray J.J.V.; Krum H.; van Veldhuisen D.J.; Swedberg K.; Shi H.; Vincent J.; Pocock S.J.; Pitt B.; Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011,364(1),11-21","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/jcm8030349","volume":"8","author":"Wongboonsin J.","year":"2019","unstructured":"Wongboonsin J.; Thongprayoon C.; Bathini T.; Ungprasert P.; Aeddula N.; Mao M.; Cheungpasitporn W.; Acetazolamide therapy in patients with heart failure: A meta-analysis. J Clin Med 2019,8(3),349","journal-title":"J Clin Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"Mullens W.","year":"2022","unstructured":"Mullens W.; Dauw J.; Martens P.; Verbrugge F.H.; Nijst P.; Meekers E.; Tartaglia K.; Chenot F.; Moubayed S.; Dierckx R.; Blouard P.; Troisfontaines P.; Derthoo D.; Smolders W.; Bruckers L.; Droogne W.; Ter Maaten J.M.; Damman K.; Lassus J.; Mebazaa A.; Filippatos G.; Ruschitzka F.; Dupont M.; Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022,387(13),1185-1195","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"Konstam M.A.","year":"2007","unstructured":"Konstam M.A.; Gheorghiade M.; Burnett J.C.; Grinfeld L.; Maggioni A.P.; Swedberg K.; Udelson J.E.; Zannad F.; Cook T.; Ouyang J.; Zimmer C.; Orlandi C.; Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA 2007,297(12),1319-1331","journal-title":"JAMA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","volume":"69","author":"Felker G.M.","year":"2017","unstructured":"Felker G.M.; Mentz R.J.; Cole R.T.; Adams K.F.; Egnaczyk G.F.; Fiuzat M.; Patel C.B.; Echols M.; Khouri M.G.; Tauras J.M.; Gupta D.; Monds P.; Roberts R.; O\u2019Connor C.M.; Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure. J Am Coll Cardiol 2017,69(11),1399-1406","journal-title":"J Am Coll Cardiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.120.051783","volume":"143","author":"Packer M.","year":"2021","unstructured":"Packer M.; Anker S.D.; Butler J.; Filippatos G.; Ferreira J.P.; Pocock S.J.; Carson P.; Anand I.; Doehner W.; Haass M.; Komajda M.; Miller A.; Pehrson S.; Teerlink J.R.; Brueckmann M.; Jamal W.; Zeller C.; Schnaidt S.; Zannad F.; Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: The EMPEROR-Reduced trial. Circulation 2021,143(4),326-336","journal-title":"Circulation"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"McMurray J.J.V.","year":"2019","unstructured":"McMurray J.J.V.; Solomon S.D.; Inzucchi S.E.; K\u00f8ber L.; Kosiborod M.N.; Martinez F.A.; Ponikowski P.; Sabatine M.S.; Anand I.S.; B\u011blohl\u00e1vek J.; B\u00f6hm M.; Chiang C.E.; Chopra V.K.; de Boer R.A.; Desai A.S.; Diez M.; Drozdz J.; Duk\u00e1t A.; Ge J.; Howlett J.G.; Katova T.; Kitakaze M.; Ljungman C.E.A.; Merkely B.; Nicolau J.C.; O\u2019Meara E.; Petrie M.C.; Vinh P.N.; Schou M.; Tereshchenko S.; Verma S.; Held C.; DeMets D.L.; Docherty K.F.; Jhund P.S.; Bengtsson O.; Sj\u00f6strand M.; Langkilde A.M.; Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019,381(21),1995-2008","journal-title":"N Engl J Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"Anker S.D.","year":"2021","unstructured":"Anker S.D.; Butler J.; Filippatos G.; Ferreira J.P.; Bocchi E.; B\u00f6hm M.; Brunner-La Rocca H.P.; Choi D.J.; Chopra V.; Chuquiure-Valenzuela E.; Giannetti N.; Gomez-Mesa J.E.; Janssens S.; Januzzi J.L.; Gonzalez-Juanatey J.R.; Merkely B.; Nicholls S.J.; Perrone S.V.; Pi\u00f1a I.L.; Ponikowski P.; Senni M.; Sim D.; Spinar J.; Squire I.; Taddei S.; Tsutsui H.; Verma S.; Vinereanu D.; Zhang J.; Carson P.; Lam C.S.P.; Marx N.; Zeller C.; Sattar N.; Jamal W.; Schnaidt S.; Schnee J.M.; Brueckmann M.; Pocock S.J.; Zannad F.; Packer M.; Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021,385(16),1451-1461","journal-title":"N Engl J Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"Solomon S.D.","year":"2022","unstructured":"Solomon S.D.; McMurray J.J.V.; Claggett B.; de Boer R.A.; DeMets D.; Hernandez A.F.; Inzucchi S.E.; Kosiborod M.N.; Lam C.S.P.; Martinez F.; Shah S.J.; Desai A.S.; Jhund P.S.; Belohlavek J.; Chiang C.E.; Borleffs C.J.W.; Comin-Colet J.; Dobreanu D.; Drozdz J.; Fang J.C.; Alcocer-Gamba M.A.; Al Habeeb W.; Han Y.; Cabrera Honorio J.W.; Janssens S.P.; Katova T.; Kitakaze M.; Merkely B.; O\u2019Meara E.; Saraiva J.F.K.; Tereshchenko S.N.; Thierer J.; Vaduganathan M.; Vardeny O.; Verma S.; Pham V.N.; Wilder\u00e4ng U.; Zaozerska N.; Bachus E.; Lindholm D.; Petersson M.; Langkilde A.M.; Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2022,387(12),1089-1098","journal-title":"N Engl J Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","volume":"342","author":"Paterna S.","year":"2011","unstructured":"Paterna S.; Fasullo S.; Cannizzaro S.; Vitrano G.; Terrazzino G.; Maringhini G.; Ganci F.; Scalzo S.; Di Pasquale P.; Parrinello G.; Basile I.; Sarullo F.M.; Cice G.; Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci 2011,342(1),27-37","journal-title":"Am J Med Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1097\/CCM.0000000000005174","volume":"49","author":"Liu C.","year":"2021","unstructured":"Liu C.; Peng Z.; Gao X.; Gajic O.; Dong Y.; Prokop L.J.; Murad M.H.; Kashani K.B.; Domecq J.P.; Simultaneous use of hypertonic saline and IV furosemide for fluid overload: A systematic review and meta-analysis. Crit Care Med 2021,49(11),e1163-e1175","journal-title":"Crit Care Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ahj.2007.01.041","volume":"154","author":"Setoguchi S.","year":"2007","unstructured":"Setoguchi S.; Stevenson L.W.; Schneeweiss S.; Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007,154(2),260-266","journal-title":"Am Heart J"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"162.e1","DOI":"10.1016\/j.amjmed.2008.08.026","volume":"122","author":"Lee D.S.","year":"2009","unstructured":"Lee D.S.; Austin P.C.; Stukel T.A.; Alter D.A.; Chong A.; Parker J.D.; Tu J.V.; \u201cDose-dependent\u201d impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med 2009,122(2),162.e1-162.e9","journal-title":"Am J Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","volume":"4","author":"Costanzo M.R.","year":"2016","unstructured":"Costanzo M.R.; Negoianu D.; Jaski B.E.; Bart B.A.; Heywood J.T.; Anand I.S.; Smelser J.M.; Kaneshige A.M.; Chomsky D.B.; Adler E.D.; Haas G.J.; Watts J.A.; Nabut J.L.; Schollmeyer M.P.; Fonarow G.C.; Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC Heart Fail 2016,4(2),95-105","journal-title":"JACC Heart Fail"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.recesp.2022.04.017","volume":"76","author":"L\u00f3pez-Vilella R","year":"2022","unstructured":"L\u00f3pez-Vilella R; S\u00e1nchez-L\u00e1zaro I; Cervera BG; Trenado VD; Orient AS; Bonet LA; Ultrafiltraci\u00f3n de acceso perif\u00e9rico como tratamiento del s\u00edndrome cardiorrenal con insuficiente respuesta diur\u00e9tica. Rev Espanola Cardiol Engl 2022,76(1),60-62","journal-title":"Rev Espanola Cardiol Engl"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","volume":"69","author":"Costanzo M.R.","year":"2017","unstructured":"Costanzo M.R.; Ronco C.; Abraham W.T.; Agostoni P.; Barasch J.; Fonarow G.C.; Gottlieb S.S.; Jaski B.E.; Kazory A.; Levin A.P.; Levin H.R.; Marenzi G.; Mullens W.; Negoianu D.; Redfield M.M.; Tang W.H.W.; Testani J.M.; Voors A.A.; Extracorporeal ultrafiltration for fluid overload in heart failure. J Am Coll Cardiol 2017,69(19),2428-2445","journal-title":"J Am Coll Cardiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","volume":"59","author":"Felker G.M.","year":"2012","unstructured":"Felker G.M.; Mentz R.J.; Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 2012,59(24),2145-2153","journal-title":"J Am Coll Cardiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","volume":"49","author":"Costanzo M.R.","year":"2007","unstructured":"Costanzo M.R.; Guglin M.E.; Saltzberg M.T.; Jessup M.L.; Bart B.A.; Teerlink J.R.; Jaski B.E.; Fang J.C.; Feller E.D.; Haas G.J.; Anderson A.S.; Schollmeyer M.P.; Sobotka P.A.; Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007,49(6),675-683","journal-title":"J Am Coll Cardiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","volume":"367","author":"Bart B.A.","year":"2012","unstructured":"Bart B.A.; Goldsmith S.R.; Lee K.L.; Givertz M.M.; O\u2019Connor C.M.; Bull D.A.; Redfield M.M.; Deswal A.; Rouleau J.L.; LeWinter M.M.; Ofili E.O.; Stevenson L.W.; Semigran M.J.; Felker G.M.; Chen H.H.; Hernandez A.F.; Anstrom K.J.; McNulty S.E.; Velazquez E.J.; Ibarra J.C.; Mascette A.M.; Braunwald E.; Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012,367(24),2296-2304","journal-title":"N Engl J Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cardfail.2013.11.004","volume":"20","author":"Marenzi G.","year":"2014","unstructured":"Marenzi G.; Muratori M.; Cosentino E.R.; Rinaldi E.R.; Donghi V.; Milazzo V.; Ferramosca E.; Borghi C.; Santoro A.; Agostoni P.; Continuous ultrafiltration for congestive heart failure: The CUORE trial. J Card Fail 2014,20(1),9-17","journal-title":"J Card Fail"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000430084","volume":"40","author":"Fran\u00e7ois K.","year":"2015","unstructured":"Fran\u00e7ois K.; Ronco C.; Bargman J.M.; Peritoneal dialysis for chronic congestive heart failure. Blood Purif 2015,40(1),45-52","journal-title":"Blood Purif"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3747\/pdi.2012.00290","volume":"34","author":"Bertoli S.V.","year":"2014","unstructured":"Bertoli S.V.; Musetti C.; Ciurlino D.; Basile C.; Galli E.; Gambaro G.; Iadarola G.; Guastoni C.; Carlini A.; Fasciolo F.; Borzumati M.; Gallieni M.; Stefania F.; Peritoneal ultrafiltration in refractory heart failure: A cohort study. Perit Dial Int 2014,34(1),64-70","journal-title":"Perit Dial Int"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3747\/pdi.2012.00149","volume":"34","author":"Courivaud C.","year":"2014","unstructured":"Courivaud C.; Kazory A.; Cr\u00e9pin T.; Azar R.; Bresson-Vautrin C.; Chalopin J.M.; Ducloux D.; Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int 2014,34(1),100-108","journal-title":"Perit Dial Int"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000321102","volume":"30","author":"Cnossen T.T.","year":"2010","unstructured":"Cnossen T.T.; Kooman J.P.; Konings C.J.A.M.; Uszko-Lencer N.H.M.K.; Leunissen K.M.L.; van der Sande F.M.; Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif 2010,30(2),146-152","journal-title":"Blood Purif"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000351202","volume":"35","author":"Kunin M.","year":"2013","unstructured":"Kunin M.; Arad M.; Dinour D.; Freimark D.; Holtzman E.J.; Peritoneal dialysis in patients with refractory congestive heart failure: Potential prognostic factors. Blood Purif 2013,35(4),285-294","journal-title":"Blood Purif"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1093\/ndt\/gfr756","volume":"27","author":"Cnossen TT","year":"2012","unstructured":"Cnossen TT; Kooman JP; Krepel HP; Konings CJAM; Uszko- Lencer NHMK; Leunissen KML; Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrol Dial Transplant 2012,27(7),2794-9","journal-title":"Nephrol Dial Transplant"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1093\/eurjhf\/hfs035","volume":"14","author":"Koch M.","year":"2012","unstructured":"Koch M.; Haastert B.; Kohnle M.; Rump L.C.; Kelm M.; Trapp R.; Aker S.; Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 2012,14(5),530-539","journal-title":"Eur J Heart Fail"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5414\/CN108038","volume":"80","author":"Rizkallah J.","year":"2013","unstructured":"Rizkallah J.; Sood M.M.; Reslerova M.; Cordova F.; Malik A.; Sathianathan C.; Estrella-Holder E.; Zieroth S.; Reduced hospitalizations in severe, refractory congestive heart failure with peritoneal dialysis: A consecutive case series. Clin Nephrol 2013,80(11),334-341","journal-title":"Clin Nephrol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/ndt\/gfp484","volume":"25","author":"S\u00e1nchez JE","year":"2010","unstructured":"S\u00e1nchez JE; Ortega T; Rodr\u00edguez C; D\u00edaz-Molina B; Mart\u00edn M; Garcia-Cueto C; Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 2010,25(2),605-10","journal-title":"Nephrol Dial Transplant"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/eurjhf\/hfs013","volume":"14","author":"N\u00fa\u00f1ez J.","year":"2012","unstructured":"N\u00fa\u00f1ez J.; Gonz\u00e1lez M.; Mi\u00f1ana G.; Garcia-Ram\u00f3n R.; Sanchis J.; Bod\u00ed V.; N\u00fa\u00f1ez E.; Puchades M.J.; Palau P.; Merlos P.; Ll\u00e0cer A.; Miguel A.; Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. Eur J Heart Fail 2012,14(5),540-548","journal-title":"Eur J Heart Fail"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","volume":"46","author":"Bart B.A.","year":"2005","unstructured":"Bart B.A.; Boyle A.; Bank A.J.; Anand I.; Olivari M.T.; Kraemer M.; Mackedanz S.; Sobotka P.A.; Schollmeyer M.; Goldsmith S.R.; Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 2005,46(11),2043-2046","journal-title":"J Am Coll Cardiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/bio.4173","volume":"37","author":"Marjani N.","year":"2022","unstructured":"Marjani N.; Dareini M.; Asadzade-Lotfabad M.; Pejhan M.; Mokaberi P.; Amiri-Tehranizadeh Z.; Saberi M.R.; Chamani J.; Evaluation of the binding effect and cytotoxicity assay of 2-Ethyl-5-(4-methylphenyl) pyramido pyrazole ophthalazine trione on calf thymus DNA: Spectroscopic, calorimetric, and molecular dynamics approaches. Luminescence 2022,37(2),310-322","journal-title":"Luminescence"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"119042","DOI":"10.1016\/j.molliq.2022.119042","volume":"356","author":"Khashkhashi-Moghadam S.","year":"2022","unstructured":"Khashkhashi-Moghadam S.; Ezazi-Toroghi S.; Kamkar-Vatanparast M.; Jouyaeian P.; Mokaberi P.; Yazdyani H.; Amiri-Tehranizadeh Z.; Reza Saberi M.; Chamani J.; Novel perspective into the interaction behavior study of the cyanidin with human serum albumin-holo transferrin complex: Spectroscopic, calorimetric and molecular modeling approaches. J Mol Liq 2022,356,119042","journal-title":"J Mol Liq"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"Wiviott S.D.","year":"2019","unstructured":"Wiviott S.D.; Raz I.; Bonaca M.P.; Mosenzon O.; Kato E.T.; Cahn A.; Silverman M.G.; Zelniker T.A.; Kuder J.F.; Murphy S.A.; Bhatt D.L.; Leiter L.A.; McGuire D.K.; Wilding J.P.H.; Ruff C.T.; Gause-Nilsson I.A.M.; Fredriksson M.; Johansson P.A.; Langkilde A.M.; Sabatine M.S.; Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2019,380(4),347-357","journal-title":"N Engl J Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"Zinman B.","year":"2015","unstructured":"Zinman B.; Wanner C.; Lachin J.M.; Fitchett D.; Bluhmki E.; Hantel S.; Mattheus M.; Devins T.; Johansen O.E.; Woerle H.J.; Broedl U.C.; Inzucchi S.E.; Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015,373(22),2117-2128","journal-title":"N Engl J Med"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230714153404","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218757\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230714153404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:42:20Z","timestamp":1695210140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218757\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":55,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230714153404","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}